S. 916 · 115th Congress
Protecting Patient Access to Emergency Medications Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the Senate without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 115th Congress ended.
R
CassidySponsor13 cosponsors · 7 D, 5 R, 1 I
R
Blunt
MB
D
Bennet
AF
D
Franken
LA
R
Alexander
LM
R
Murkowski
PM
D
Murray
JB
R
Boozman
AK
I
King
JH
R
Hoeven
RB
D
Blumenthal
HH
D
Heitkamp
AK
D
Klobuchar
SW
D
Whitehouse3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- Senate Introduced Apr 24, 2017
- Senate Passed May 23, 2018
Protecting Patient Access to Emergency Medications Act of 2017
What it does: CRS summary · Reported to Senate with amendment(s) · May 1, 2017
Protecting Patient Access to Emergency Medications Act of 2017
(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.
An EMS agency may obtain a single registration in each state instead of a separate registration for each location.
A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.
An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.
The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.
(Sec. 3) A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions.
The Government Accountability Office must report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Latest action (May 25, 2018): Held at the desk.
Policy area: Health · Origin: Senate · Introduced: Apr 24, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- Senate Introduced Apr 24, 2017
- Senate Passed May 23, 2018
No recorded floor vote found.